Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late stage pharmaceutical company with a broad ...

30 at his home in New York City at age 48. He had been diagnosed with metastatic melanotic peripheral nerve sheath sarcoma, a rare and aggressive form of cancer in July, his partner told The New ...

‌Etienne G, Guilhot J, Rea D, et al. Long-term follow-up of the French Stop Imatinib (STIM1) study in patients with chronic myeloid leukemia. J Clin Oncol . 2017;35(3):298-305. doi:10.1200/JCO ...

Introduction: Ewing Sarcoma (EWS) has been reported in seven children with Down syndrome (DS). To date, a detailed assessment of this solid tumour in DS patients is yet to be made. Methods: Here, we ...

Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida. *Corresponding Author: Jatinder K. Lamba, Department of Pharmacotherapy and ...

Acute myeloid leukemia is a type of cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells. The cancer develops from myeloid blasts cells that would ...

It was approved through the accelerated pathway for patients 60 years or older with CD33-positive acute myeloid leukemia after their first relapse who are not considered candidates for cytotoxic ...

Findings from the phase 3 SIERRA study showed that Iomab-B was associated with a higher durable complete response rate vs allogeneic cell transplant in older patients with relapsed/refractory acute ...

Annamycin is currently being evaluated in ongoing clinical trials for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases. Annamycin ...